Watching the market bounce higher off of late-2018 drop that nearly pushed the major market indices to bear market levels means that it starts to get tempting to think that it’s a good time to start jumping back into stocks and get ready for the rally back to the next set of market highs. The […]
Read MoreArrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company offers ARO-AAT, a RNA interference (RNAi) therapeutic candidate for the treatment of liver disease related to alpha-1 antitrypsin deficiency; ARO-APOC3 to treat hypertriglyceridemia; ARO-ANG3 to reduce production of angiopoietin-like protein 3; ARO-ENaC to reduce production of the epithelial […]
Read More